PropertyValue
?:abstract
  • Hydroxychloroquine (HCQ) is a drug that is used for both chemoprophylaxis and treatment of COVID-19. At the moment, HCQ maintain its popularity and tens of thousands of people across the world are still receiving the current drug.1 After the COVID-19 pandemic, several cutaneous side effects of HCQ are reported.2-7 Herein, we reported generalized exanthema after a single dose of using HCQ. A 58-year-old male patient presented with resistant rashes on his upper extremities and neck region. Rashes appeared all over the body along with severe pruritus just a day after receiving a single 200 mg dose of oral hydroxychloroquine for COVID-19 prophylaxis.
is ?:annotates of
?:creator
?:journal
  • Int_J_Clin_Pract
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Generalized exanthema due to hydroxychloroquine as a popular drug during COVID-19 prophylaxis
?:type
?:who_covidence_id
  • #894760
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/0bqe64fj>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/0bqe64fj>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all